We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
EFSA Reviews Control Measures of Bluetongue
News

EFSA Reviews Control Measures of Bluetongue

EFSA Reviews Control Measures of Bluetongue
News

EFSA Reviews Control Measures of Bluetongue

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "EFSA Reviews Control Measures of Bluetongue"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Mass vaccination programmes lasting at least five years in combination with improved, continuous surveillance systems would be the only effective measures for eradicating bluetongue in Europe, EFSA has concluded. EFSA’s experts have reviewed control measures for bluetongue and options for safe trade of animals from infected to free areas, following a request from the European Commission. They have also updated their scientific advice on epidemiological aspects of the disease, particularly its transmission patterns.

Eradication of bluetongue is very difficult – at least five consecutive years of vaccination covering 95% of susceptible cattle and sheep would be needed, the experts concluded. Such mass vaccination campaigns would have to be followed by sensitive surveillance systems capable of detecting low levels of virus prevalence, lower than 1% of animals in a monitored area. The disease could otherwise re-appear some years after completion of the vaccination campaign.

Surveillance systems should be defined on a case-by-case basis taking into account aspects such as the geographical area monitored and the epidemiological phase of the disease.

Experts also highlighted that:

  • New-born animals receive antibodies from their mothers that protect them from the disease for about three months. However, these antibodies may interfere with vaccination, thus making vaccination ineffective during this period. Immunity starts in most cases 21 days after the second dose of the basic vaccination scheme.
  • Some species of the midges that transmit the disease are active throughout the year – especially in mild-winter areas such as the Mediterranean basin. In these areas, transmission of the virus may occur at any time. In colder areas, such as in northern Europe, midges are inactive for about three winter months, during which transmission is halted.

In line with EFSA’s “Promoting Methods for Evidence Use” approach , EFSA’s Panel on Animal Health and Welfare captured the strategy for performing this risk assessment in a protocol that documents all the steps taken in reaching its final conclusions. This new approach enhances the robustness and transparency of the scientific process.

EFSA’s scientific advice will assist policy-makers as they review legislation on bluetongue. EFSA will classify different types of bluetongue according to their characteristics by the end of June 2017. This will help identify specific protection and control measures.

This article has been republished from materials provided by EFSA. Note: material may have been edited for length and content. For further information, please contact the cited source.

Advertisement